Evidence map›Paper›PMID 23738839›Full record

ArticleJournal of the American Chemical Society2013

Divin: a small molecule inhibitor of bacterial divisome assembly.

Ye-Jin Eun, Maoquan Zhou, Daniela Kiekebusch, Susan Schlimpert, Rishi R Trivedi, Somenath Bakshi, Zhou Zhong, Taylor A Wahlig, Martin Thanbichler, Douglas B Weibel

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Imaging Bacterial Cell Wall Biosynthesis.Annual review of biochemistry · 2018
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ye-Jin EunDepartment of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Maoquan Zhou
Daniela Kiekebusch
Susan Schlimpert
Rishi R Trivedi
Somenath Bakshi
Zhou Zhong
Taylor A Wahlig
Martin Thanbichler
Douglas B Weibel
Max Planck Institute for Terrestrial Microbiology · DEPhilipps University of Marburg · DEUniversity of Wisconsin–Madison · US

Funding

Revisiting the bacterial cell wall as a target for new antibioticsDP2OD008735 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI WEIBEL, DOUGLAS BENJAMIN · 2011 to 2011
$2.3M
NIH HHS 1DP2OD008735-01NIH HHS DP2 OD008735
6 · The paper itself

Abstract

Bacterial cell division involves the dynamic assembly of division proteins and coordinated constriction of the cell envelope. A wide range of factors regulates cell division--including growth and environmental stresses--and the targeting of the division machinery has been a widely discussed approach for antimicrobial therapies. This paper introduces divin, a small molecule inhibitor of bacterial cell division that may facilitate mechanistic studies of this process. Divin disrupts the assembly of late division proteins, reduces peptidoglycan remodeling at the division site, and blocks compartmentalization of the cytoplasm. In contrast to other division inhibitors, divin does not interact with the tubulin homologue FtsZ, affect chromosome segregation, or activate regulatory mechanisms that inhibit cell division indirectly. Our studies of bacterial cell division using divin as a probe suggest that dividing bacteria proceed through several morphological stages of the cell envelope, and FtsZ is required but not sufficient to compartmentalize the cytoplasmic membrane at the division site. Divin is only moderately toxic to mammalian cells at concentrations that inhibit the growth of clinical pathogens. These characteristics make divin a useful probe for studying bacterial cell division and a starting point for the development of new classes of therapeutic agents.

Indexed as

Anti-Bacterial AgentsBenzimidazolesCaulobacter crescentusCell DivisionDose-Response Relationship, DrugDrug DiscoveryEscherichia coliHydrazinesMicrobial Sensitivity TestsMolecular StructureNaphthalenesSmall Molecule LibrariesStructure-Activity RelationshipAnti-Bacterial AgentsBenzimidazolesHydrazinesNaphthalenesN'-((E)-(2-hydroxynaphthalen-1-yl)methylidene)-3-(2-methyl-1H-benzimidazol-1-yl)propanehydrazideSmall Molecule Libraries

Identifiers

PMID23738839
PMCPMC3738872
OpenAlexW1970379020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.